https://orcid.org/0000-0002-5006-9394
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fulton F. Velez, Danmeng Huang, Lorie Mody & Daniel C. Malone. (2022) Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 599-607.
Read now
Read now
Articles from other publishers (4)
Joseph E. Glass, Caitlin N. Dorsey, Tara Beatty, Jennifer F. Bobb, Edwin S. Wong, Lorella Palazzo, Deborah King, Jessica Mogk, Kelsey Stefanik-Guizlo, Abisola Idu, Dustin Key, John C. Fortney, Rosemarie Thomas, Angela Garza McWethy, Ryan M. Caldeiro & Katharine A. Bradley. (2023) Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implementation Science 18:1.
Crossref
Crossref
Cecilia L. BergeriaEric C. Strain. (2022) Opioid Use Disorder: Pernicious and Persistent. American Journal of Psychiatry 179:10, pages 708-714.
Crossref
Crossref
Mary M. Sweeney, August F. Holtyn, Maxine L. Stitzer & David R. Gastfriend. (2022) Practical Technology for Expanding and Improving Substance Use Disorder Treatment. Psychiatric Clinics of North America 45:3, pages 515-528.
Crossref
Crossref
Hayam Y. Giravi, Zack Biskupiak, Linda S. Tyler & Grzegorz Bulaj. (2022) Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care. Frontiers in Digital Health 4.
Crossref
Crossref